Cytokines and Chemokines in SARS-CoV-2 Infections—Therapeutic Strategies Targeting Cytokine Storm
出版年份 2021 全文链接
标题
Cytokines and Chemokines in SARS-CoV-2 Infections—Therapeutic Strategies Targeting Cytokine Storm
作者
关键词
-
出版物
Biomolecules
Volume 11, Issue 1, Pages 91
出版商
MDPI AG
发表日期
2021-01-13
DOI
10.3390/biom11010091
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- COVID-19: combining antiviral and anti-inflammatory treatments
- (2020) Justin Stebbing et al. LANCET INFECTIOUS DISEASES
- Clinical Characteristics of Coronavirus Disease 2019 in China
- (2020) Wei-jie Guan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pathological findings of COVID-19 associated with acute respiratory distress syndrome
- (2020) Zhe Xu et al. Lancet Respiratory Medicine
- Targeting the inflammatory cascade with anakinra in moderate to severe COVID-19 pneumonia: case series
- (2020) Achille Aouba et al. ANNALS OF THE RHEUMATIC DISEASES
- Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy
- (2020) Paola Toniati et al. AUTOIMMUNITY REVIEWS
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- The cytokine storm in COVID-19: An overview of the involvement of the chemokine/chemokine-receptor system
- (2020) Francesca Coperchini et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Impact of low dose tocilizumab on mortality rate in patients with COVID-19 related pneumonia
- (2020) Ruggero Capra et al. European Journal of Internal Medicine
- Off-label use of tocilizumab for the treatment of SARS-CoV-2 pneumonia in Milan, Italy
- (2020) Valentina Morena et al. European Journal of Internal Medicine
- COVID-19: A New Virus, but a Familiar Receptor and Cytokine Release Syndrome
- (2020) Toshio Hirano et al. IMMUNITY
- Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality
- (2020) Chi Zhang et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis
- (2020) Jing Yang et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19
- (2020) Yang Yang et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Tocilizumab for the treatment of severe coronavirus disease 2019
- (2020) Rand Alattar et al. JOURNAL OF MEDICAL VIROLOGY
- COVID‐19 pneumonia treated with Sarilumab: a clinical series of eight patients
- (2020) Maurizio Benucci et al. JOURNAL OF MEDICAL VIROLOGY
- Tocilizumab therapy reduced intensive care unit admissions and/or mortality in COVID-19 patients
- (2020) T. Klopfenstein et al. MEDECINE ET MALADIES INFECTIEUSES
- Viral and host factors related to the clinical outcome of COVID-19
- (2020) Xiaonan Zhang et al. NATURE
- Covid-19 and Kidney Transplantation
- (2020) Enver Akalin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical characteristics and outcomes of patients with severe covid-19 with diabetes
- (2020) Yongli Yan et al. BMJ Open Diabetes Research & Care
- Characterization of the Inflammatory Response to Severe COVID-19 Illness
- (2020) Oliver J McElvaney et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation: an open-label cohort study
- (2020) Emanuel Della-Torre et al. ANNALS OF THE RHEUMATIC DISEASES
- Tocilizumab Treatment for Cytokine Release Syndrome in Hospitalized COVID-19 Patients
- (2020) Christina C. Price et al. CHEST
- Tocilizumab for severe COVID-19: a systematic review and meta-analysis
- (2020) Shao-Huan Lan et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Early Identification of COVID-19 Cytokine Storm and Treatment with Anakinra or Tocilizumab
- (2020) Annette Langer-Gould et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Serum Cytokine and Chemokine Profile in Relation to the Severity of Coronavirus Disease 2019 in China
- (2020) Ying Chi et al. JOURNAL OF INFECTIOUS DISEASES
- The cytokine storm and COVID‐19
- (2020) Biying Hu et al. JOURNAL OF MEDICAL VIROLOGY
- The Janus kinase 1/2 inhibitor ruxolitinib in COVID-19 with severe systemic hyperinflammation
- (2020) F. La Rosée et al. LEUKEMIA
- Early IL-1 receptor blockade in severe inflammatory respiratory failure complicating COVID-19
- (2020) Raphaël Cauchois et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Use of Anakinra to Prevent Mechanical Ventilation in Severe COVID‐19: A Case Series
- (2020) Iris Navarro‐Millán et al. Arthritis & Rheumatology
- The Impact of Pre-existing Comorbidities and Therapeutic Interventions on COVID-19
- (2020) Lauren A. Callender et al. Frontiers in Immunology
- Outcomes and biomarker analyses among patients with COVID-19 treated with interleukin 6 (IL-6) receptor antagonist sarilumab at a single institution in Italy
- (2020) Vincenzo Montesarchio et al. Journal for ImmunoTherapy of Cancer
- Longitudinal COVID-19 profiling associates IL-1RA and IL-10 with disease severity and RANTES with mild disease
- (2020) Yan Zhao et al. JCI Insight
- Clinical and pathological investigation of patients with severe COVID-19
- (2020) Shaohua Li et al. JCI Insight
- SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2
- (2020) Thomas Mandel Clausen et al. CELL
- Inhibition of cytokine signaling by ruxolitinib and implications for COVID-19 treatment
- (2020) Swamy Yeleswaram et al. CLINICAL IMMUNOLOGY
- A score combining early detection of cytokines accurately predicts COVID-19 severity and intensive care unit transfer
- (2020) Carole Nagant et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Characterization of the cytokine storm reflects hyperinflammatory endothelial dysfunction in COVID-19
- (2020) Jonathan T. Sims et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- The role of IL-6 and other mediators in the cytokine storm associated with SARS-CoV-2 infection
- (2020) Ana Copaescu et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Cytokine release syndrome in COVID-19: Innate immune, vascular, and platelet pathogenic factors differ in severity of disease and sex
- (2020) Aaron C. Petrey et al. JOURNAL OF LEUKOCYTE BIOLOGY
- The Janus kinase 1/2 inhibitor ruxolitinib in COVID-19
- (2020) Alessandro Gozzetti et al. LEUKEMIA
- An inflammatory cytokine signature predicts COVID-19 severity and survival
- (2020) Diane Marie Del Valle et al. NATURE MEDICINE
- A dynamic COVID-19 immune signature includes associations with poor prognosis
- (2020) Adam G. Laing et al. NATURE MEDICINE
- Efficacy of Tocilizumab in Patients Hospitalized with Covid-19
- (2020) John H. Stone et al. NEW ENGLAND JOURNAL OF MEDICINE
- Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: A living systematic review and meta-analysis
- (2020) Diana Buitrago-Garcia et al. PLOS MEDICINE
- Addition of Tocilizumab to the Standard of Care Reduces Mortality in Severe COVID-19: A Systematic Review and Meta-Analysis
- (2020) Umesha Boregowda et al. Frontiers in Medicine
- Pleiotropy and Specificity: Insights from the Interleukin 6 Family of Cytokines
- (2019) Masaaki Murakami et al. IMMUNITY
- Tocilizumab for the treatment of chimeric antigen receptor T cell-induced cytokine release syndrome
- (2019) Chelsea Kotch et al. Expert Review of Clinical Immunology
- Profile of sarilumab and its potential in the treatment of rheumatoid arthritis
- (2017) Maria Gabriella Raimondo et al. Drug Design Development and Therapy
- Clinical Progression and Cytokine Profiles of Middle East Respiratory Syndrome Coronavirus Infection
- (2016) Eu Suk Kim et al. JOURNAL OF KOREAN MEDICAL SCIENCE
- The Acute Respiratory Distress Syndrome: From Mechanism to Translation
- (2015) SeungHye Han et al. JOURNAL OF IMMUNOLOGY
- Anti-TNF therapy: past, present and future
- (2014) C. Monaco et al. INTERNATIONAL IMMUNOLOGY
- Delayed induction of proinflammatory cytokines and suppression of innate antiviral response by the novel Middle East respiratory syndrome coronavirus: implications for pathogenesis and treatment
- (2013) S. K. P. Lau et al. JOURNAL OF GENERAL VIROLOGY
- Tocilizumab – A novel therapy for non-organ-specific autoimmune diseases
- (2012) Lisa Kaly et al. BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
- The Acute Respiratory Distress Syndrome: Pathogenesis and Treatment
- (2011) Michael A. Matthay et al. Annual Review of Pathology-Mechanisms of Disease
- Maraviroc in the treatment of HIV infection
- (2010) Neela Ray Drug Design Development and Therapy
- Activation and Regulation of Systemic Inflammation in ARDS
- (2009) G. Umberto Meduri et al. CHEST
- Chemokines and chemokine receptors in mucosal homeostasis at the intestinal epithelial barrier in inflammatory bowel disease
- (2008) Noah P. Zimmerman et al. INFLAMMATORY BOWEL DISEASES
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now